nih ghk-cu | C28H48CuN12O8 | CID 133697840 Injectable GHK-Cu: Beginner's Guide to
Description
Woods at St

Its less invasive and easier to integrate into a nightly routine

From the reference product sponsors perspective, the most effective defense is not litigation but authorized biosimilar strategy: licensing a biosimilar partner to produce a version of the molecule under the sponsors own brand or at a deep discount, capturing the biosimilar market while preventing uncontrolled price erosion

So good question, Seth

From a value perspective, combining NAD+, BPC-157, and GHK-Cu into one patch reduces overall cost and treatment burden